Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ZYDUS LIFESCIENCES SUN PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 43.2 34.2 126.2% View Chart
P/BV x 6.9 5.8 120.2% View Chart
Dividend Yield % 0.7 0.6 118.9%  

Financials

 SUN PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    SUN PHARMA
Mar-23
ZYDUS LIFESCIENCES
Mar-23
SUN PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,072495 216.6%   
Low Rs790319 247.3%   
Sales per share (Unadj.) Rs182.9170.3 107.4%  
Earnings per share (Unadj.) Rs35.719.8 180.4%  
Cash flow per share (Unadj.) Rs46.226.9 171.7%  
Dividends per share (Unadj.) Rs11.506.00 191.7%  
Avg Dividend yield %1.21.5 83.8%  
Book value per share (Unadj.) Rs233.4173.0 134.9%  
Shares outstanding (eoy) m2,399.341,012.20 237.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.12.4 212.8%   
Avg P/E ratio x26.120.6 126.7%  
P/CF ratio (eoy) x20.115.1 133.1%  
Price / Book Value ratio x4.02.4 169.5%  
Dividend payout %32.230.3 106.2%   
Avg Mkt Cap Rs m2,233,361412,144 541.9%   
No. of employees `000NANA-   
Total wages/salary Rs m82,96024,564 337.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m438,857172,374 254.6%  
Other income Rs m8,1994,746 172.7%   
Total revenues Rs m447,055177,120 252.4%   
Gross profit Rs m112,90029,677 380.4%  
Depreciation Rs m25,2947,227 350.0%   
Interest Rs m1,7201,299 132.4%   
Profit before tax Rs m94,08425,897 363.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,4765,878 144.2%   
Profit after tax Rs m85,60820,019 427.6%  
Gross profit margin %25.717.2 149.4%  
Effective tax rate %9.022.7 39.7%   
Net profit margin %19.511.6 168.0%  
BALANCE SHEET DATA
Current assets Rs m398,619100,082 398.3%   
Current liabilities Rs m199,06455,267 360.2%   
Net working cap to sales %45.526.0 174.9%  
Current ratio x2.01.8 110.6%  
Inventory Days Days14750 292.3%  
Debtors Days Days9594 101.7%  
Net fixed assets Rs m376,960144,776 260.4%   
Share capital Rs m2,3991,012 237.1%   
"Free" reserves Rs m557,555174,146 320.2%   
Net worth Rs m559,954175,158 319.7%   
Long term debt Rs m00-   
Total assets Rs m775,794244,940 316.7%  
Interest coverage x55.720.9 266.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.7 80.4%   
Return on assets %11.38.7 129.3%  
Return on equity %15.311.4 133.8%  
Return on capital %17.115.5 110.2%  
Exports to sales %039.2 0.0%   
Imports to sales %011.9 0.0%   
Exports (fob) Rs mNA67,577 0.0%   
Imports (cif) Rs mNA20,544 0.0%   
Fx inflow Rs m154,05367,577 228.0%   
Fx outflow Rs m71,51120,544 348.1%   
Net fx Rs m82,54147,033 175.5%   
CASH FLOW
From Operations Rs m49,59326,888 184.4%  
From Investments Rs m-79,43711,712 -678.3%  
From Financial Activity Rs m23,761-44,004 -54.0%  
Net Cashflow Rs m1,155-5,338 -21.6%  

Share Holding

Indian Promoters % 54.5 75.0 72.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.6 18.0 202.9%  
FIIs % 17.1 5.0 342.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 25.0 181.9%  
Shareholders   612,626 306,495 199.9%  
Pledged promoter(s) holding % 2.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Sun Pharma vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sun Pharma vs Cadila Healthcare Share Price Performance

Period Sun Pharma Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.77% 0.57% 1.18%
1-Month 3.00% 7.77% -0.75%
1-Year 64.65% 107.52% 61.82%
3-Year CAGR 39.45% 32.30% 18.16%
5-Year CAGR 27.78% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sun Pharma share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Sun Pharma hold a 54.5% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sun Pharma and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Sun Pharma paid a dividend of Rs 11.5 per share. This amounted to a Dividend Payout ratio of 32.2%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Sun Pharma, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.